NEPHROS INC
NEPHNasdaq
$3.78
↑ +0.5%Jul 17 close · end-of-day
Price
1Y↑ +9.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$41.5M
Enterprise Value
$37.5M
P/E
54.0
P/S
2.2
P/B
3.9
EV/EBITDA
46.5
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$19.1M
Net Income (TTM)
$776,000.00
Free Cash Flow (TTM)
—
Gross Margin
60.0%
Operating Margin
3.5%
Net Margin
4.1%
ROE
7.2%
ROIC
8.0%
Debt / Equity
—
Net Cash
$4.0M
Return 1Y
+5.6%
Company profile
Nephros, Inc. develops and sells high performance water solutions to medical and commercial markets. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
- CEO
- Andrew Astor
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 30
- Headquarters
- New Jersey
- Website
- nephros.com
Management & directors
- Banks Robert R. Jr.President and CEO
- Krandel JudyChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
NEPH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$5.2M↑ +6.9%
Diluted EPS$0.01↓ -80.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $8.6M | $10.2M | $10.0M | $14.2M | $14.2M | $18.8M |
| Gross profit | $4.9M | $5.6M | $4.7M | $8.4M | $8.7M | $11.6M |
| Operating income | -$4.3M | -$3.3M | -$4.3M | -$1.6M | $6,000.00 | $1.1M |
| Net income | -$4.5M | -$3.9M | — | -$1.6M | $74,000.00 | $1.2M |
| Diluted EPS | — | — | -$0.73 | -$0.15 | $0.01 | $0.11 |
| Operating cash flow | -$6.9M | -$1.4M | -$3.2M | $827,000.00 | -$492,000.00 | $1.6M |
| Free cash flow | -$7.1M | -$1.5M | -$3.4M | $752,000.00 | -$547,000.00 | — |
| Gross margin | 57.4% | 55.1% | 47.4% | 59.0% | 61.6% | 61.9% |
| Operating margin | -49.9% | -31.8% | -43.5% | -11.2% | 0.0% | 6.1% |
| Net margin | -52.9% | -37.8% | — | -11.1% | 0.5% | 6.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3M | $3.5M | $3.9M | $4.9M | $4.4M | $4.8M | $4.7M | $5.2M |
| Gross profit | $1.9M | $2.1M | $2.5M | $3.2M | $2.8M | $2.9M | $2.8M | $3.0M |
| Operating income | -$317,000.00 | $206,000.00 | $317,000.00 | $566,000.00 | $248,000.00 | $314,000.00 | $18,000.00 | $97,000.00 |
| Net income | -$289,000.00 | $183,000.00 | $349,000.00 | $558,000.00 | $237,000.00 | $337,000.00 | $62,000.00 | $140,000.00 |
| Diluted EPS | -$0.03 | $0.02 | $0.04 | $0.05 | $0.02 | $0.03 | $0.01 | $0.01 |
| Operating cash flow | -$501,000.00 | -$623,000.00 | $1.3M | $322,000.00 | $994,000.00 | $99,000.00 | $185,000.00 | -$1.7M |
| Free cash flow | — | -$623,000.00 | — | — | — | — | — | — |
| Gross margin | 58.8% | 61.1% | 64.0% | 64.7% | 63.2% | 61.2% | 58.4% | 57.4% |
| Operating margin | -9.7% | 5.9% | 8.2% | 11.6% | 5.6% | 6.6% | 0.4% | 1.9% |
| Net margin | -8.9% | 5.2% | 9.0% | 11.4% | 5.4% | 7.1% | 1.3% | 2.7% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-11 | AMRON ARTHUR H | Award | 3,574 | $0.00 | $0.00 | filing |
| 2026-03-23 | Banks Robert R. Jr.· President and CEO | Option exercise | 120,000 | $1.44 | $172,800.00 | filing |
| 2026-03-23 | Krandel Judy· Chief Financial Officer | Option exercise | 68,861 | $1.71 | $117,752.31 | filing |
| 2026-03-16 | AMRON ARTHUR H | Award | 3,610 | $0.00 | $0.00 | filing |
| 2025-11-10 | Nettis Lisa Marie | Award | 1,622 | $0.00 | $0.00 | filing |
| 2025-11-10 | Spandow Oliver J. | Award | 8,036 | $0.00 | $0.00 | filing |
| 2025-11-10 | AMRON ARTHUR H | Award | 5,391 | $0.00 | $0.00 | filing |
Latest 7 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.